Phillip Pang - 06 Oct 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Chief Medical Officer
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 06 Oct 2021
Net transactions value: -$172,780
Form type: 4
Filing time: 07 Oct 2021, 18:14:09 UTC
Previous filing: 29 Sep 2021
Next filing: 22 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Sale	$172,780	-5,000	-4.6%	$34.56	104,277	06 Oct 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.